LAVIPHARM S.A.
Announcement of Regulated Information
Lavipharm S.A. announces that Mr. Christodoulos Maniatis, son of Periklis, Group Chief Financial Officer, sold 10.000 common Lavipharm shares, amounting to 32.000,00 Euros, on Wednesday, November 30, 2007 and 4.600 common Lavipharm shares, amounting to 14.812,00 Euros, on Thursday, November 29, 2007.